Published January 16, 2019
UB’s Clinical and Translational Science Institute (CTSI) has recognized two Jacobs School of Medicine and Biomedical Sciences faculty members for their clinical research work.
The awards, now in their third year, honor outstanding accomplishments in clinical research performed at a Buffalo Translational Consortium (BTC) institution with investigators from the University at Buffalo or Roswell Park Comprehensive Cancer Center serving as the lead authors. The research must have been published or in press in the past 12 months.
Jeffrey M. Lackner, PsyD, professor of medicine and chief of the Division of Behavioral Medicine, received the BTC’s 2018 Clinical Research Achievement Award for a study titled “Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome,” published in the July 2018 issue of Gastroenterology.
Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of the Division of Endocrinology, Diabetes and Metabolism, was recognized as an award finalist for a study titled “Efficacy and Safety of Dapaglifloxin in Patients with Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study,” published in the December 2018 issue of Diabetes Care.
Michael J. LaMonte, PhD, associate professor of epidemiology and environmental health in UB’s School of Public Health and Health Professions, was also recognized as an award finalist for a study on heart failure in postmenopausal women.
“Our Clinical Research Achievement Awards are designed to highlight the most innovative and impactful clinical research being performed by clinical researchers throughout the Buffalo Translational Consortium,” said Anne B. Curtis, MD, SUNY Distinguished Professor, Charles and Mary Bauer Professor and chair of medicine.
“These research studies have directly led to improvements in the health and well-being of patients in our community and beyond,” Curtis added.
The BTC awards competition seeks to identify major advances resulting from the region’s investment in research to benefit the health and welfare of the Western New York community. To be eligible for an award, the research should contribute to the understanding of human disease and physiology and demonstrate an impact on the understanding, prevention and diagnosis or treatment of disease.
“These three clinical studies by outstanding research teams report important advances that will make a real difference in improving health,” said Timothy F. Murphy, MD, senior associate dean for clinical and translational research and director of the CTSI.
“They were chosen from an impressive group of submissions from BTC investigators,” said Murphy, SUNY Distinguished Professor of medicine. “They align perfectly with the vision of the CTSI to perform innovative research to improve the health of our community and the nation.”
The award winner and finalists will be given a travel stipend to attend Translational Science 2019 in Washington, D.C.